These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6274837

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K, Nagatake T, Uzuka Y, Harada T, Rikitomi N.
    Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High performance liquid chromatographic assay of cefsulodin, cefotiam and cefmenoxime in serum and urine.
    Itakura K, Mitani M, Aoki I, Usui Y.
    Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):622-7. PubMed ID: 6284390
    [No Abstract] [Full Text] [Related]

  • 7. Renal tubular mechanisms for excretion of cefpiramide (SM-1652) in association with its long-lasting pharmacokinetic properties.
    Matsui H, Okuda T.
    J Pharmacobiodyn; 1988 Feb; 11(2):67-73. PubMed ID: 3379566
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
    Joly V, Pangon B, Brion N, Vallois JM, Carbon C.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):695-700. PubMed ID: 3042958
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A novel method to predict the elimination half-lives and the renal excretion mechanisms of cephalosporins.
    Komiya I, Nishio M, Murata S, Chiba F, Sakurai T, Shinkai S, Fujita M.
    J Pharmacobiodyn; 1984 Aug; 7(8):545-55. PubMed ID: 6512677
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Pharmacokinetic behavior of cefsulodin and cefotiam alone or in combination after intravenous injection of 1 gram].
    Fourtillan JB, Bryskier A, Lefebvre MA, Ingrand I.
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):501-5. PubMed ID: 6087247
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Intraocular penetration of systemically administered cephalosporins under steady-state conditions in animal experiments].
    Völker B, Mester U, Mendel N.
    Ophthalmologica; 1985 Jun; 191(1):29-34. PubMed ID: 3861992
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of the new cephalosporins.
    Brogard JM, Comte F.
    Antibiot Chemother (1971); 1982 Jun; 31():145-210. PubMed ID: 6277241
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.